Exchange: NASDAQ·Updated 07:30 PM EDT
RLMD logo

RLMD Relmada Therapeutics Inc

$4.12
$0.08
(1.91%)
Today
Closed $4.12
$0.00
(0.00%)
After Hours
EarningsNov 12
Mkt Cap$439.48M
Vol2.07M

About RLMD

Relmada Therapeutics, Inc. engages in the development of clinical-stage drugs. The firm's pipeline includes NDV-01 and Sepranolone. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.
59

Bullish Sentiment

How do you feel about RLMD?

Advertisement|Remove ads.